Sign InTTOO Stock: Volatility and Speculation Drive Recent Growth While Long-Term Prospects Remain Uncertain
Summary
T2 Biosystems, Inc. (TTOO) is a health diagnostics company with a small market capitalisation that has gained meme status on Wall Street, resulting in a surge in stock prices; however, its negative EPS and lack of profitability suggest caution for long-term investors, making it more suitable for speculative traders. (Analysis conducted on August 16, 2023)
Fundamental Analysis
T2 Biosystems, Inc., ticker TTOO, is a health diagnostics company listed on the NASDAQ. It has a relatively small market capitalisation at $14.16 million, with 24.89 million shares outstanding. The company reported an Earnings Per Share (EPS) value of -$8.18, which is concerning as it indicates the company is not profitable yet. This is reflected in the company's current P/E ratio of -0.07.
News surrounding TTOO suggests that the stock has gained meme status on Wall Street, resulting in an increase of 400% in the last month. The company's shares have had a series of rallies, with stock prices rising significantly. Such behaviour often indicates speculation and can lead to volatility. Therefore, the surge in price should not be misconstrued as an endorsement of the company's fundamental strength.
Technical Analysis
Looking at TTOO's technical indicators, the stock last closed at 0.57USD on August 16, 2023. It's experienced a decrease of 0.02 (-3.77%) from the previous trading day. Over the past year, TTOO's stock price has ranged between a high of $7.65 and a low of $0.054.
The 50-day Moving Average, which provides a look into the short-term trend of a stock price, stands well below the last close at $0.14, while the 200-day Moving Average, which reflects a broader trend, is above at $0.80. Both these figures indicate that TTOO's stock is currently outperforming its short-term trend but underperforming in the longer term.
The RSI14, a momentum oscillator that measures the speed and change of price movements, stands at 81. An RSI over 70 typically denotes a stock being overbought that might be primed for a trend reversal or corrective pullback in price.
The resistance level, which refers to the price level that an asset does not surpass for a period, is at $0.59, which is slightly above the stock's last close of $0.57.
Forecast and Evaluation
Given the technical indicators and current stock behaviour, there seems to be some risk of volatility with this stock in the short term. Such fluctuations may arise as a result of the stock's apparent meme status, which is known for sparking sudden, substantial price movements.
Given the company's current EPS and P/E ratio, it is not profitable hence this presents risks for investment in the long term. Thus, T2 Biosystems, Inc. appears to be more suited to speculative traders rather than long-term investors.
For the next trading day on August 17, 2023, the stock could hover around the resistance level of $0.59, but expect high volatility. As for the upcoming week, it is difficult to pinpoint an exact estimate due to the stock's currently unstable nature.
Final Evaluation
TTOO stock is currently a HOLD. Even though the stock has seen significant growth recently, this seems predominantly driven by speculative trading rather than the company's fundamental strength. Long-term investors should be wary of the company's negative EPS and consider risk tolerance before investing, while traders might see potential given the increased volatility and volume. Future investment decisions should be made after carefully observing if T2 Biosystems, Inc., starts to show signs of consistent profitability, and after further research into the company's financial health and future business prospects.
